Reversal of Cognitive Impairment in an Elderly Parkinsonian Patient by Transcranial Application of Picotesla Electromagnetic Fields

References

• Ajuriaguerra J., Muller M., Tissot R. A propos de quelques problemes poses par l'apraxie dans les demences. Encephale 1960; 49: 275–401
   Google Scholar
• Alvord E. C. The pathology of Parkinsonism: Part II. An interpretation with special reference to other changes in the aging brain. Recent advances in parkinson's disease, F. H. McDowell, C. H. Markham. Davis, Philadelphia 1971
   Google Scholar
• Anden N. E., Carlsson A., Kerstell J., Magnusson T., Olsson R., Roos B. E., Steen B., Steg G., Svanborg A., Thieme G., Werdinius B. Oral L-DOPA treatment of parkinsonism. Acta Medica Scandinavica 1970; 187: 247–256
   PubMedGoogle Scholar
• Arrigoni G., De Renzi E. Constructional apraxia and hemispheric locus of lesion. Cortex 1964; 1: 170–197
   Google Scholar
• Azmitia E. C., Gannon P. J. Primate serotonergic system: a review of human and animal studies and a report on Macaca fascicularis. Advances in Neurology 1986; 43: 407–468
   PubMedGoogle Scholar
• Battersby W. S., Bender M. B., Pollack M., Kahn R. L. Unilateral “spatial agnosia” in patients with cortical lesions. Brain 1956; 79: 68–93
   PubMed Web of Science ®Google Scholar
• Baumgarten H. G., Lachenmayer L. Anatomical features and physiological properties of central serotonin neurons. Pharmacopsychiatrie 1985; 18: 180–187
   PubMed Web of Science ®Google Scholar
• Beardsley J. V., Puletti F. Personality (Mmpi) and cognitive (Wais) changes after levodopa treatment. Archives of Neurology 1971; 25: 145–150
   PubMedGoogle Scholar
• Bentin S., Silverberg R., Gordon H. W. Asymmetrical cognitive deterioration in demented and parkinsonian patients. Cortex 1981; 17: 533–544
   PubMed Web of Science ®Google Scholar
• Benton A. L., Fogel M. L. Three-dimensional constructional praxis. Archives of Neurology 1962; 7: 347–354
   PubMed Web of Science ®Google Scholar
• Berger B. Histochemical identification and localization of dopaminergic axons in rat and human cerebral cortex. Advances in Biochemical Psychopharmacology 1977; 16: 13–20
   PubMedGoogle Scholar
• Boller F., Mizutani T., Roessmann U., Gambetti P. Parkinson disease, dementia, and Alzheimer's disease: clinicopathologic correlations. Annals of Neurology 1980; 7: 329–335
   PubMed Web of Science ®Google Scholar
• Boller F., Passafiume D., Keefe N. C., Rogers K., Morrow L., Kim V. Visuospatial impairment in Parkinson's disease. Role of perceptual and motor factors. Archives of Neurology 1984; 41: 485–490
   PubMed Web of Science ®Google Scholar
• Bowen F. P., Hoehn M. M., Yahr M. D. Parkinsonism: alterations in spatial orientation as determined by a route-walking test. Neuropsychoogia 1972; 10: 355–361
   PubMed Web of Science ®Google Scholar
• Brozoski T. J., Brown R. M., Rosvold H. E., Goldman P. S. Cognitive deficit caused by regional depletion of dopamine in prefrontal cortex of rhesus monkey. Science 1979; 205: 929–932
   PubMed Web of Science ®Google Scholar
• Candy J. M., Perry R. H., Perry E. K. Pathological changes in the nucleus basalis of Meynert in Alzheimer's and Parkinson's diseases. Journal of Neurological Sciences 1983; 54: 277–289
   Google Scholar
• Comings D. E. Tourette syndrome and human behavior. Hope Press, Duarte, CA. 1990; 341–361
   Google Scholar
• De Renzi E., Faglioni P. The relationship between visuospatial impairment and constructional apraxia. Cortex 1967; 3: 327–342
   Google Scholar
• DeRenzi E., Faglioni P., Scotti G. Hemispheric contribution to exploration of space through the visual and tactile modality. Cortex 1970; 6: 191–203
   PubMedGoogle Scholar
• Descarries L., Beaudet A., Watkins K. C. Serotonin nerve terminal in adult rat neocortex. Brain Research 1975; 100: 563–588
   PubMed Web of Science ®Google Scholar
• Direnfeld L. K., Albert L. M., Lolicer L., Langlais P. J., Marquis I., Kaplan E. Parkinson's disease: the possible relationship of laterality to dementia and neurochemical findings. Archives of Neurology 1984; 41: 935–941
   PubMed Web of Science ®Google Scholar
• Forno L. S., Norville R. L. Synaptic morphology in the human locus coeruleus. Acta Neuropathologica 1981; 53: 7–14
   PubMed Web of Science ®Google Scholar
• Forno L. S., Barbour P. J., Norville R. L. Presenile dementia with Lewy bodies and neu- rofibrillay tangles. Archives of Neurology 1978; 35: 818–822
   PubMedGoogle Scholar
• Freedman M., Leach L., Kaplan E., Winocur G., Shulman K. I., Delis D. C. Clock drawing: a neuropsychological analysis. Oxford University Press, New York 1994; 6–8
   Google Scholar
• Gainotti G., Tiacci C. Patterns of drawing disability in right and left hemispheric patients. Neuropsychologia 1970; 8: 379–384
   PubMed Web of Science ®Google Scholar
• Gibb W. R. G. Dementia and Parkinson's disease. British Journal of Psychiatry 1989; 154: 596–614
   PubMed Web of Science ®Google Scholar
• Goldenberg G., Podreka I., Muller C., Deecke L. The relationship between cognitive deficits and frontal lobe functions in patients with Parkinson's disease: An emission computerized tomography study. Behavoral Neurology 1989; 2: 79–87
   Google Scholar
• Granerus A. K. Factors influencing the occurrence of “on-off” symptoms during long-term treatment with L-DOPA. Acta Medica Scandinavica 1978; 203: 75–85
   PubMedGoogle Scholar
• Hakim A. M., Mathieson G. Dementia in Parkinson's disease: a neuropathologic study. Neurology 1979; 29: 1209–1214
   PubMed Web of Science ®Google Scholar
• Halgin R., Riklan M., Misiak H. Levodopa, parkinsonism and recent memory. Journal of Nervous and Mental Disease 1977; 164: 268–272
   PubMed Web of Science ®Google Scholar
• Heilman K. M., Watson R. T., Valenstein E. Neglect and related disorders. Clinical neuropsychology, K. M. Heilman, E. Valenstein. Oxford University Press, Oxford 1985; 243–293
   Google Scholar
• Henderson V. W., Mack W., Williams B. W. Spatial disorientation in Alzheimer's disease. Archives of Neurology 1989; 46: 391–394
   PubMed Web of Science ®Google Scholar
• Hoehn M. M., Yahr M. D. Parkinsonism: onset, progression and mortality. Neurology 1967; 17: 427–442
   PubMed Web of Science ®Google Scholar
• Hornykiewicz O. Brain neurotransmitter changes in Parkinson's disease. Movement disorders, C. D. Marsden, S. Fahn. Butterworths, London 1982; 41–58
   Google Scholar
• Hovestadt A., De Jong G. J., Meerwaldt J. D. Spatial disorientation in Parkinson's disease: no effect of levodopa substitution therapy. Neurology 1988; 38: 1802–1803
   PubMed Web of Science ®Google Scholar
• Hughes A. J., Daniel S. E., Blankson S., Lees A. J. A clinicopathologic study of 100 cases of Parkinson's disease. Archives of Neurology 1993; 50: 140–148
   PubMed Web of Science ®Google Scholar
• Javoy-Agid F., Agid Y. Is the mesocortical dopaminergic system involved in Parkinson's disease. Neurology 1980; 30: 1326–1330
   PubMed Web of Science ®Google Scholar
• Kirk A., Kertesz A. Hemispheric contributions to drawing. Neuropsychologia 1989; 27: 881–886
   PubMed Web of Science ®Google Scholar
• Kirk A., Kertesz A. On drawing impairment in Alzheimer's disease. Archives of Neurology 1991; 48: 73–77
   PubMed Web of Science ®Google Scholar
• Klawans H. L. Psychiatric side effects during the treatment of Parkinson's disease. Journal of Neural Transmission 1988; 27: 117–122, (suppl)
   Google Scholar
• Kleist K. Kriegsverletzungen des Gehirns. Handbuch der Artzlichen Erfahrungen im Weltkrieg: 1914–1918, O. Schjerning. Barth, LeipzigGermany 1922
   Google Scholar
• Korczyn A. D., Inzelberg R., Treves T., Neufeld M., Reider I., Rabey P. M. Dementia of Parkinson's disease. Advances in Neurology, M. D. Yahr, K. J. Bergmann. Raven Press, New York 1986; 399–403
   Google Scholar
• Kuhl D. E., Metter E. J., Benson D. F. Similarities of cerebral glucose metabolism in Alzheimer's and parkinsonian dementia. Journal of Cerebral Blood Flow and Metabolism 1985; 5: S169, (suppl)
   Google Scholar
• Larrabee G. J., Kane R. L. Differential drawing size associated with unilateral brain damage. Neuropsychologia 1983; 21: 173–177
   PubMed Web of Science ®Google Scholar
• Lebrun Y., Hoops R. Intelligence and aphasia. Swets & Zeitlinger B. V., Amsterdam 1974
   Google Scholar
• Leverenz J., Sumi S. M. Parkinson's disease in patients with Alzheimer's disease. Archives of Neurology 1986; 43: 662–664
   PubMed Web of Science ®Google Scholar
• Levin B. E., Llabre M. M., Reisman S., Weiner W. J., Sanchez-Ramos J., Singer C., Brown M. C. Visuospatial impairment in Parkinson's disease. Neurology 1991; 41: 365–369
   PubMed Web of Science ®Google Scholar
• Lezak M. D. Neuropsychological assessment Third Edition. Oxford University Press, New York 1995; 581–587
   Google Scholar
• Lhermitte J., Trelles J. O. Sur l'apraxie pure constructive. Encephale 1933; 28: 413–444
   Google Scholar
• Lindvall O., Bjorklund A., Moore R. Y., Stenevi U. Mesencephalic dopamine neurons projecting to neocortex. Brain Research 1974; 81: 325–331
   PubMed Web of Science ®Google Scholar
• Loranger A. W., Goodell H., McDowell F. H., Lee J. E., Sweet R. D. Intellectual impairment in Parkinson's disease. Brain 1972; 95: 405–412
   PubMed Web of Science ®Google Scholar
• Mayer-Gross W. Some observations on apraxia. Proceedings of the Royal Society of Medicine 1935; 28: 1203–1212
   PubMedGoogle Scholar
• Mayeux R. Mental state. Handbook of parkinson's disease, W. C. Roller. Marcel Dekker, New York 1987; 127–144
   Google Scholar
• Mayeux R., Stern Y., Rosen J. Visuospatial function in Parkinson's disease. Neurology 1980; 30: 392
   Web of Science ®Google Scholar
• Mayeux R., Stern Y., Rosen J., Levenfhal J. Depression, intellectual impairment and Parkinson's disease. Neurology 1981; 31: 645–650
   PubMed Web of Science ®Google Scholar
• Mayeux R., Stern Y., Sano M., Cote L., Williams J. B. W. Clinical and biochemical correlates of bradyphrenia in Parkinson's disease. Neurology 1987; 37: 1130–1134
   PubMed Web of Science ®Google Scholar
• Mesulam M. M. A cortical network for directed attention and unilateral neglect. Annals of Neurology 1981; 10: 304–325
   Web of Science ®Google Scholar
• McCance-Katz E. F., Marek K. L., Price L. H. Serotonergic dysfunction in depression associated with Parkinson's disease. Neurology 1992; 42: 1813–1814
   PubMed Web of Science ®Google Scholar
• McFie J., Zangwill O. L. Visual constructive disabilities associated with lesion of the left cerebral hemisphere. Brain 1960; 83: 243–260
   Web of Science ®Google Scholar
• Mohr E., Juncos J., Cox C., Litvan I., Fedio P., Chase T. N. Selective deficits in cognition and memory in high-functioning Parkinsonian patients. Journal of Neurology, Neurosurgery and Psychiatry 1990; 53: 603–606
   PubMed Web of Science ®Google Scholar
• Mortimer J. A., Pirozzolo F. J., Hansen E. C., Webster D. D. Relationship of motor symptoms to intellectual deficits in Parkinson's disease. Neurology 1982; 32: 133–137
   PubMed Web of Science ®Google Scholar
• Nagasaki H., Kosaka K., Nakamura R. Distribution of rhythm formation in patients with hemispheric lesion. Tohoku Journal of Experimental Medicine 1981; 135: 231–236
   PubMed Web of Science ®Google Scholar
• Nausieda P. A., Weiner W. J., Kaplan L. R., Weber S., Klawans H. L. Sleep disruption in the course of chronic levodopa therapy: An early feature of the levodopa psychosis. Clinical Neuropharmacology 1982; 5: 183–194
   PubMed Web of Science ®Google Scholar
• Nutt J. G., Hammerstand J. P., Gancher S. T. Parkinson's disease-100maxims. Edward Arnold, London 1992; 112–113
   Google Scholar
• Ogden J. A., Growdon J. H., Corkin S. Deficits on visuospatial tests involving forward planning in high-functioning parkinsonians. Neuropsychiatry, Neuropsychology and Behavioral Neurology 1990; 3: 125–139
   Google Scholar
• Oxbury J. M., Campbell D. C., Oxbury S. M. Unilateral spatial neglect and impairments of spatial analysis and visual perception. Brain 1974; 97: 551–564
   PubMed Web of Science ®Google Scholar
• Paterson A., Zangwill O. L. Disorders of visual space perception associated with lesions of the right cerebral hemisphere. Brain 1944; 67: 331–358
   Google Scholar
• Pearce J. M. S., Flowers K., Pearce J., Pratt A. E. Clinical, psychometric and CAT scan correlations in Parkinson's disease. Research progress in Parkinson's disease, F. Clifford Rose, R. Capildeo. Pitman Medical, Kent 1981; 43–52
   Google Scholar
• Piccirilli M., D'Alessandro P., Finali G., Piccinin G. L., Agostini L. Frontal lobe dysfunction in Parkinson's disease: prognostic value for dementia. European Neurology 1989; 29: 71–76
   PubMed Web of Science ®Google Scholar
• Pillon B., Dubois B., Bonnet A. M., Esteguy M., Guimaraes J., Vigouret J. M., L'hermitte F., Agid Y. Cognitive slowing in Parkinson's disease fails to respond to levodopa treatment: the 15-objects test. Neurology 1989; 39: 762–768
   PubMed Web of Science ®Google Scholar
• Pirozzolo F. J., Hansen E. C., Mortimer J. A. Dementia in Parkinson's disease: A neuropsychological analysis. Brain and Cognition 1982; 1: 71–83
   PubMedGoogle Scholar
• Reading P. J. Frontal lobe dysfunction in schizophrenia and Parkinson's disease- a meeting point for neurology, psychology and psychiatry: discussion paper. Journal of the Royal Society of Medicine 1991; 84: 349–353
   PubMed Web of Science ®Google Scholar
• Riklan M., Zahn T. P., Diller L. Human figure drawings before and after chemosurgery of the basal ganglia in Parkinsonism. Journal of Nervous and Mental Disease 1962; 135: 500–506
   PubMed Web of Science ®Google Scholar
• Rinne J. O., Rummukainen J., Paljarvi L., Rinne U. K. Dementia in Parkinson's disease is related to neuronal loss in the medial substantia nigra. Annals of Neurology 1989; 26: 47–50
   PubMed Web of Science ®Google Scholar
• Rosenblum W. I., Ghatak N. R. Lewy bodies in the presence of Alzheimer's disease. Archives of Neurology 1979; 36: 170–171
   PubMedGoogle Scholar
• Sacks O., Kohl M. S., Messeloff C. R., Schwartz W. F. Effects of levodopa in parkinsonian patients with dementia. Neurology 1972; 22: 516–519
   PubMed Web of Science ®Google Scholar
• Sandyk R. Magnetic fields in the therapy of parkinsonism. International Journal of Neuroscience 1992; 66: 209–235
   PubMed Web of Science ®Google Scholar
• Sandyk R. The effects of picotesla range magnetic fields on perceptual organization and visual memory in parkinsonism. International Journal of Neuroscience 1993; 73: 207–219
   PubMed Web of Science ®Google Scholar
• Sandyk R. Reversal of a visuoconstructional deficit in Parkinson's disease by application of external magnetic fields: A report of five cases. International Journal of Neuroscience 1994a; 75: 213–228
   PubMed Web of Science ®Google Scholar
• Sandyk R. A drug naive Parkinsonian patient successfully treated with electromagnetic fields. International Journal of Neuroscience 1994b; 79: 99–110
   PubMed Web of Science ®Google Scholar
• Sandyk R. Improvement in word fluency performance in Parkinson's disease by administration of electromagnetic fields. International Journal of Neuroscience 1994c; 77: 23–46
   PubMedGoogle Scholar
• Sandyk R. Weak electromagnetic fields reverse visuospatial hemi-inattention in Parkinson's disease. International Journal of Neuroscience 1995a; 81: 47–65
   PubMedGoogle Scholar
• Sandyk R. Reversal of a visuospatial deficit on the clock drawing test in Parkinson's disease by treatment with weak electromagnetic fields. International Journal of Neuroscience 1995b; 82: 255–268
   PubMed Web of Science ®Google Scholar
• Sandyk R. Improvement in short-term visual memory by weak electromagnetic fields in Parkinson's disease. International Journal of Neuroscience 1995c; 81: 67–82
   PubMedGoogle Scholar
• Sandyk R. Improvement of body image perception in Parkinson's disease by treatment with weak electromagnetic fields. International Journal of Neuroscience 1995d; 82: 269–283
   PubMed Web of Science ®Google Scholar
• Sandyk R. Electromagnetic fields improve visuospatial performance and reverse agraphia in a Parkinsonian patient. International Journal of Neuroscience 1996a; 87: 209–217
   PubMed Web of Science ®Google Scholar
• Sandyk R. The long term impact of treatment with electromagnetic fields on visual memory in Parkinson's disease. International Journal of Neuroscience 1996b; 86: 257–262
   PubMed Web of Science ®Google Scholar
• Sandyk R., Derpapas K. Further observations on the unique efficacy of picotesla magnetic fields in Parkinson's disease. International Journal of Neuroscience 1993a; 69: 167–183
   PubMedGoogle Scholar
• Sandyk R., Derpapas K. The effects of external picotesla range magnetic fields on the EEG in Parkinson's disease. International Journal of Neuroscience 1993b; 70: 85–96
   PubMedGoogle Scholar
• Sandyk R., Fisher H. Serotonin in involuntary movement disorders. International Journal of Neuroscience 1988; 42: 185–205
   PubMed Web of Science ®Google Scholar
• Sandyk R., Lacono R. P. Rapid improvement of visuoperceptive functions by picotesla range magnetic fields in Parkinson's disease. International Journal of Neuroscience 1993a; 70: 233–254
   PubMedGoogle Scholar
• Sandyk R., Iacono R. P. Reversal of visual neglect in Parkinson's disease by treatment with picotesla range magnetic fields. International Journal of Neuroscience 1993b; 73: 93–107
   PubMedGoogle Scholar
• Sano M., Stern Y., Williams J., Cote L., Rosenstein R., Mayeux R. Coexisting dementia and depression in Parkinson's disease. Archives of Neurology 1989; 46: 1284–1286
   PubMedGoogle Scholar
• Scatton B., Rouquier L., Javoy-Agid F., Agid Y. Dopamine deficiency in the cerebral cortex in Parkinson disease. Neurology 1982; 32: 1039–1040
   PubMed Web of Science ®Google Scholar
• Simon H., Scatton B., LeMoal M. Dopaminergic A10 neurones are involved in cognitive functions. Nature 1980; 286: 150–151
   PubMed Web of Science ®Google Scholar
• Sjogren T., Sjogren H., Lindgren A. G. H. Morbus Alzheimer and morbus Pick. Acta Psychiatrica Neurologica Scandinavica 1952; 82: 1–152, (suppl)
   Google Scholar
• Sweet R. D., McDowell F. H., Feigenson J. S. Mental symptoms in Parkinson's disease during chronic treatment with levodopa. Neurology 1976; 26: 305–310
   PubMed Web of Science ®Google Scholar
• Starkstein S. E., Preziosi T. J., Berthier M. L., Bolduc P. L., Mayberg H. S., Robinson R. G. Depression and cognitive impairment in Parkinson's disease. Brain 1989; 112: 1141–1153
   PubMed Web of Science ®Google Scholar
• Stern Y., Richards M., Sano M., Mayeux R. Comparison of cognitive changes in patients with Alzheimer's and Parkinson's disease. Archives of Neurology 1993; 50: 1040–1045
   PubMedGoogle Scholar
• Sulkava R., Haltia M., Paetau A. Accuracy of clinical diagnosis in primary degenerative dementia: correlation with neuropathological findings. Journal of Neurology, Neurosurgery and Psychiatry 1983; 46: 9–13
   PubMed Web of Science ®Google Scholar
• Taylor E. M. The appraisal of children with cerebral deficits. Harvard University Press, Cambridge, Mass 1959
   Google Scholar
• Tohgi H., Abe T., Takahashi S., Takahashi J., Hamato H. Alterations in the concentration of serotonergic and dopaminergic substances in the cerebrospinal fluid of patients with Parkinson's disease and their changes after L-DOPA administration. Neuroscience Letters 1993; 159: 135–138
   PubMed Web of Science ®Google Scholar
• Torack R. M., Morris J. C. The association of ventral tegmental area histopathology with adult dementia. Archives of Neurology 1988; 45: 497–501
   PubMed Web of Science ®Google Scholar
• Uhl G. R., Hedreen J. C., Price D. L. Parkinson's disease: loss of neurons from the ventral tegmental area contralateral to therapeutic surgical lesions. Neurology 1985; 35: 1215–1218
   PubMed Web of Science ®Google Scholar
• Villardita C., Smirni P., Le Pira F. Mental deterioration, visuoperceptive disabilities and constructional apraxia in Parkinson's disease. Acta Neurologica Scandinavica 1982; 66: 112–120
   PubMed Web of Science ®Google Scholar
• Villardita C., Smirni P., Zappala G. Visual neglect in Parkinson's disease. Archives of Neurology 1983; 40: 737–739
   PubMed Web of Science ®Google Scholar
• Whitehouse P. J., Hedreen J. C., While C. L., Price D. L. Basal forebrain neurons in the dementia of Parkinson disease. Annals of Neurology 1983; 13: 243–248
   PubMed Web of Science ®Google Scholar
• Wolf-Klein G. P., Silverstone F. A., Levy A. P., Brod M. S. Screening for Alzheimer's disease by clock drawing. Journal of the American Geriatrics Society 1989; 37: 730–734
   PubMed Web of Science ®Google Scholar
• Yagishita S., Itoh Y., Amano N., Nakano T. Atypical senile dementia with widespread Lewy type inclusion body in the cerebral cortex. Acta Neuropathologica 1979; 49: 187–191
   Web of Science ®Google Scholar
• Yanagisawa N., Fujimoto S., Ueno E. Neurophysiological aspects of Parkinson's disease. Current problems in treatment ofparkinson's disease, Y. Kuroiwa, Y. Toyokura. DMW, TokyoJapan 1985; 13–22
   Google Scholar